Evidence supports the energy-boosting effects of tesofensine: Because of its potent antidepressant effect, tesofensine has also been studied for its therapeutic benefits on sexual dysfunction, according to studies: Studies reported that triple reuptake inhibitor such as tesofensine also holds therapeutic potential for eating disorders: ADHD is characterized by short attention span, hyperactivity, and impulsivity, and is common in children and even adults
Putting It Into Practice Studies suggest that GLP-1s can be a powerful tool for improving patient outcomes related to weight management, T2DM, and CVD
To begin, you complete a medical assessment, this includes entering weight loss goals and your health history
In a head-to-head comparison, tirzepatide users lost an average of about 20% of body weight over 72 weeks, versus roughly 15% with semaglutide (source: NEJM)
Some patients notice appetite changes within the first few weeks
PlexusDx annualized pricing at month-to-month rates: Microdose GLP-1 Protocol $1,548/year ($129/mo flat), Semaglutide Injection $2,268/year ($189/mo, or $1,788/year at $149/mo on the 6-month plan), Tirzepatide Injection $3,468/year ($289/mo, or $2,988/year at $249/mo on the 6-month plan), GLP-Squared $3,468/year ($289/mo)